A new study questioned the clinical utility of an algorithm meant to predict opioid use disorder (OUD) risk based on 15 genetic variants. In a case-control analysis of more than 450,000 adults, the 15 ...

A quiet signal inside a tumor may soon guide how surgeons treat early lung cancer. Researchers now report that hidden genetic ...

About a year ago, the US Food and Drug Administration (FDA) granted premarket approval to AvertD (SOLVD Health), the first genetic test to assess an individual’s risk of developing opioid use disorder ...

Recent years have seen direct-to-consumer (DTC) genetic testing for cancer susceptibility change dramatically. For one, a new model now dominates the market where tests are advertised to consumers but ...

NPR's Ari Shapiro talks with two bioethicists about the ethics of and access to genetic testing, and the power of knowing one's genetic makeup. Yesterday we told the story of our public radio ...